Sep 30, 2016

Gilead Sciences Q3 2016 Earnings Report

Total Revenue
$7.5B
Previous year: $8.3B
-9.6%
EPS
$2.75
Previous year: $3.22
-14.6%
Gross Profit
$6.37B
Previous year: $7.23B
-11.9%
Cash and Equivalents
$9.81B
Previous year: $14B
-29.8%
Free Cash Flow
$4.13B
Total Assets
$56.6B
Previous year: $50.6B
+11.8%

Gilead Sciences

Gilead Sciences